SCHEMBL6283253

SCHEMBL6283253

Cc1cc(C)cc(-c2nc(-c3ccc(CSCc4ccc(-c5nc(-c6cc(C)cc(C)c6)c(-c6ccncc6)s5)cc4)cc3)sc2-c2ccncc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 4/20 0.53
PTGS2 P35354 1/20 0.46
ADORA3 P0DMS8 6/20 0.43
ADORA1 P30542 4/20 0.43
ADORA2A P29274 2/20 0.43
CHRM5 P08912 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
ADORA2B P29275 1/20 0.43
CDC7 O00311 3/20 0.39
DBF4 Q9UBU7 3/20 0.39
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
DRD4 P21917 1/20 0.37
TSPO P30536 1/20 0.37
DRD3 P35462 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
ALOX5 P09917 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283030 0.86 MAPK14 (0.49) MAPK14PTGS2CDC7DBF4IDO1
SCHEMBL6283249 0.86 MAPK14 (0.54) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6504993 0.84 MAPK14 (0.54) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6285570 0.83 MAPK14 (0.54) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6280438 0.83 MAPK14 (0.59) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6276678 0.82 PTGS2 (0.62) MAPK14PTGS2ALOX5KDM4E
SCHEMBL6286370 0.82 MEN1 (0.50) MAPK14PTGS2CDC7DBF4IDO1
SCHEMBL6605134 0.81 MAPK14 (0.53) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6508320 0.79 MAPK14 (0.55) MAPK14PTGS2ADORA3ADORA1ADORA2A
SCHEMBL6504016 0.79 MAPK14 (0.81) MAPK14PTGS2ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1205478-A1 p38MAP KINASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2002-05-15 EP claimed
US-6962933-B1 Method for inhibiting p38 MAP kinase or TNF-α production using a 1,3-thiazole TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-11-08 US disclosed
EP-1205478-A1 p38MAP KINASE INHIBITORS Takeda Chemical Industries, Ltd. (JP) 2002-05-15 EP disclosed